385608005: Darbepoetin alfa (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Renal hormone\Erythropoietin receptor agonist\Darbepoetin alfa
\Substance categorized by disposition\Receptor agonist\Erythropoietin receptor agonist\Darbepoetin alfa

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hematologic agent (substance)\Haematinic\Erythropoietin receptor agonist\Darbepoetin alfa
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\Renal hormone\Erythropoietin receptor agonist\Darbepoetin alfa

\Biological substance (substance)\Hematopoietic factor\Erythropoietin receptor agonist\Darbepoetin alfa

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1479812011 Darbepoetin alfa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2463858016 Darbepoetin alfa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3216381000005118 darbepoetin alfa da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Darbepoetin alfa	Is a	Erythropoietin	false	Inferred relationship	Some
Darbepoetin alfa	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Renal hormone (disposition)	false	Inferred relationship	Some
Darbepoetin alfa	Is a	Erythropoietin receptor agonist	true	Inferred relationship	Some
Darbepoetin alfa	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Erythropoietin receptor agonist (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing darbepoetin alfa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Darbepoetin alfa	Inferred relationship	Some	1
darbepoetin alfa 25 µg/ml injektionsvæske, opløsning, hætteglas a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
darbepoetin alfa 40 µg/ml injektionsvæske, opløsning, hætteglas a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
darbepoetin alfa 60 µg/ml injektionsvæske, opløsning, hætteglas a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
darbepoetin alfa 100 µg/ml injektionsvæske, opløsning, hætteglas a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
darbepoetin alfa 200 µg/ml injektionsvæske, opløsning, hætteglas a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
Darbepoetin alfa 150micrograms/0.3mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
Darbepoetin alfa 100micrograms/0.5mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
Darbepoetin alfa 80micrograms/0.4mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
Darbepoetin alfa 60micrograms/0.3mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
Darbepoetin alfa 50micrograms/0.5mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
Darbepoetin alfa 40micrograms/0.4mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
Darbepoetin alfa 30micrograms/0.3mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
Darbepoetin alfa 20micrograms/0.5mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
Darbepoetin alfa 15micrograms/0.375mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
Darbepoetin alfa 10micrograms/0.4mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
darbepoetin alfa 15 µg/0,375 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
darbepoetin alfa 20 µg/0,5 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
darbepoetin alfa 30 µg/0,3 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
darbepoetin alfa 40 µg/0,4 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
darbepoetin alfa 50 µg/0,5 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
darbepoetin alfa 60 µg/0,3 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
darbepoetin alfa 80 µg/0,4 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
darbepoetin alfa 100 µm/0,5 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
darbepoetin alfa 150 µm/0,3 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
darbepoetin alfa 10 µm/0,4 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
darbepoetin alfa 300 µg/0,6 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
darbepoetin alfa + albumin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
darbepoetin alfa + polysorbat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
darbepoetin alfa 500 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Darbepoetin alfa	Inferred relationship	Some
Product containing precisely darbepoetin alfa 500 microgram/1 milliliter conventional release solution for injection syringe	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Darbepoetin alfa	Inferred relationship	Some	1
Product containing precisely darbepoetin alfa 500 microgram/1 milliliter conventional release solution for injection syringe	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Darbepoetin alfa	Inferred relationship	Some	1
Product containing darbepoetin alfa in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Darbepoetin alfa	Inferred relationship	Some	1
Product containing only darbepoetin alfa (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Darbepoetin alfa	Inferred relationship	Some	1
Product containing only darbepoetin alfa in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Darbepoetin alfa	Inferred relationship	Some	1
Product containing precisely darbepoetin alfa 500 microgram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Darbepoetin alfa	Inferred relationship	Some	1
Product containing precisely darbepoetin alfa 500 microgram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Darbepoetin alfa	Inferred relationship	Some	1
Darbepoetin alfa 100 microgram/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Darbepoetin alfa	Inferred relationship	Some	1
Darbepoetin alfa 100 microgram/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Darbepoetin alfa	Inferred relationship	Some	1
Darbepoetin alfa 40 microgram/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Darbepoetin alfa	Inferred relationship	Some	1
Darbepoetin alfa 40 microgram/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Darbepoetin alfa	Inferred relationship	Some	1
Product containing precisely darbepoetin alfa 25 microgram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Darbepoetin alfa	Inferred relationship	Some	1
Product containing precisely darbepoetin alfa 25 microgram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Darbepoetin alfa	Inferred relationship	Some	1
Product containing precisely darbepoetin alfa 200 microgram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Darbepoetin alfa	Inferred relationship	Some	1
Product containing precisely darbepoetin alfa 200 microgram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Darbepoetin alfa	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1479812011	Darbepoetin alfa	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2463858016	Darbepoetin alfa (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3216381000005118	darbepoetin alfa	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)